American Society of Hematology

Fig. 4.

$Fig. 4. Freedom from progression in 119 patients with recurrent or refractory HD treated with high-dose therapy and autografting according to number of prognostic factors. See text for description of prognostic factors. (A) None (n = 46), solid line; one (n = 39), dotted line, two (n = 23), dot and dash line; three (n = 6), grey line. (B) None (n = 46), solid line or 1 to 3 unfavorable prognostic factors (n = 68), dotted line.$

Freedom from progression in 119 patients with recurrent or refractory HD treated with high-dose therapy and autografting according to number of prognostic factors. See text for description of prognostic factors. (A) None (n = 46), solid line; one (n = 39), dotted line, two (n = 23), dot and dash line; three (n = 6), grey line. (B) None (n = 46), solid line or 1 to 3 unfavorable prognostic factors (n = 68), dotted line.

This Feature Is Available To Subscribers Only